FOR IMMEDIATE RELEASE                                 DHC Contact: Christine Franklin
Phone: 410-344-7580
Email: [email protected]

DHC Membership and Research Expand In Advance of Fall Summits at AstraZeneca and Genentech

Brooklyn, NY (September 16, 2019) The DHC (Digital Health Coalition), an educational non-profit association focused on the biopharma industry, welcomes this month a diverse new group of corporate members.  Heading into the DHC’s fall summit season, Conde Nast, WEGO Health, RxEdge and meltmedia are joining the already expansive group of DHC members committed to advancing industry innovation relevant to digital marketing of healthcare products and services.

DHC Executive Director Christine Franklin spoke to the rapid membership growth, saying, “As the worlds of digital health, and digital marketing, have continued to expand, evolve, and elicit insights from thought leaders, we are proud to expand our membership with companies in the media, technology, and patient education space. We are excited about the future of digital health, digital marketing, and our network.”

With this growth of membership and strategic partnership, the DHC will also expand its work in the area of industry research projects. A study into physician attitudes towards in-office education and marketing will be fielded this month with members PatientPoint and SERMO, results to be presented first to DHC members and attendees at the West Coast Summit hosted by Genentech on November 14th.  The addition of corporate member WEGO Health brings a wealth of insights through their patient influencer network, benefiting DHC members in the form of quarterly surveys to be analyzed and shared to the DHC network. 

DHC membership will participate in an Executive Industry Landscape survey in the fourth quarter of 2019, with participating thought leaders granted a first look at the results. Survey summary and insights will be provided to the wider industry via the DHC website.  

Mark Bard (DHC Co-Founder) reinforced the unique relationship value between membership and increased research opportunities, saying, “We are committed to the important work of uncovering challenges and delivering answers through innovative research that affirms the value of technology and inspires members to invest and adapt to the new world of digital health.”

Finally, the DHC is looking forward to gathering its membership and new interested healthcare marketers at this fall’s two upcoming DHC Summits – first at AstraZeneca on October 8th and then convening West Coast members at Genentech on November 14th. Each event will bring together thought leaders, research experts, and change makers to openly discuss current challenges, hear exclusive reports from DHC projects, and trigger new ideas on innovation. Content will be provided by curated thought leaders and innovators.  DHC events are supported and attended by corporate members and current employees of pharmaceutical and biotech companies – in line with DHC’s mission to drive education in digital health marketing.  Event details are available at


The Digital Health Coalition ( a 501(c)(3) nonprofit created to serve as the collective voice and industry rallying point for the discussion of the current and future issues relevant to digital marketing of healthcare products and services. The DHC engages multiple and diverse stakeholders through research, events, and advocacy projects and then recommend specific actions that will drive innovation.The DHC seeks member companiesto help improve the use of digital technologies to engage patients and providers, and to advocate for biopharma’s role as a key stakeholder in the healthcare ecosystem.